Matthew Foehr

COO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Ligand Pharmaceuticals Inc (LGND)	Former President and Chief Operating Officer	$451,057	—	$2,041,319	$1,400,037	—	$115,353	$4,007,766
2021	Ligand Pharmaceuticals Inc (LGND)	Former President and Chief Operating Officer	$518,933	—	$3,146,844	$1,226,357	$259,467	$130,603	$5,282,204
2020	Ligand Pharmaceuticals Inc (LGND)	Former President and Chief Operating Officer	$503,750	—	$1,242,269	$1,303,366	$277,063	$158,001	$3,484,449
2019	Ligand Pharmaceuticals Inc (LGND)	President and Chief Operating Officer	$487,500	—	$1,711,163	$1,686,480	$195,000	$164,766	$4,244,909
2018	Ligand Pharmaceuticals Inc (LGND)	President and Chief Operating Officer	$458,931	—	$1,361,147	$1,164,133	$252,412	$87,517	$3,324,140
2017	Ligand Pharmaceuticals Inc (LGND)	President and Chief Operating Officer	$442,094	$30,000	$1,387,985	$1,280,493	$265,256	$52,675	$3,458,503

Executive changes

Resigned Ligand's President and Chief Operating Officer at Ligand Pharmaceuticals Inc (LGND)
2022-11-01

Earnings-call appearances

Ligand Pharmaceuticals Inc Q2 FY2022 Earnings Call
Ligand Pharmaceuticals Inc (LGND)

2022-08-08
Ligand Pharmaceuticals Inc Q2 FY2021 Earnings Call
Ligand Pharmaceuticals Inc (LGND)

2021-07-29
Ligand Pharmaceuticals Inc Q1 FY2021 Earnings Call
Ligand Pharmaceuticals Inc (LGND)

2021-05-03
Ligand Pharmaceuticals Inc Q3 FY2020 Earnings Call
Ligand Pharmaceuticals Inc (LGND)

2020-10-30